1. Preprocedural high - sensitivity C-reactive protein (hsCRP) decrease during intensive atorvastatin therapy: the presumable impact on atherosclerosis progression after coronary stenting
   A M Shchinova et al, 2019, Terapevticheskii arkhiv CrossRef
2. Rosmarinic Acid Inhibits Platelet Aggregation and Neointimal Hyperplasia In Vivo and Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration In Vitro via Activation of the Keap1-Nrf2-ARE Antioxidant System
   Chen Chen et al, 2022, Journal of Agricultural and Food Chemistry CrossRef
3. Rational Design of Lovastatin-Loaded Spherical Reconstituted High Density Lipoprotein for Efficient and Safe Anti-Atherosclerotic Therapy
   Cuiping Jiang et al, 2019, Molecular Pharmaceutics CrossRef
4. Modulating Plaque Inflammation via Targeted mRNA Nanoparticles for the Treatment of Atherosclerosis
   Mingzhu Gao et al, 2023, ACS Nano CrossRef
5. Insulin Resistance Promotes Early Atherosclerosis via Increased Proinflammatory Proteins and Oxidative Stress in Fructose-Fed ApoE-KO Mice
   Beatriz Cannizzo et al, 2012, Experimental Diabetes Research CrossRef
6. Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress
   Lintao Wang et al, 2017, Scientific Reports CrossRef
7. MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
   Emma L. Solly et al, 2019, Journal of Clinical Medicine CrossRef
8. Doxycycline Decreases Atherosclerotic Lesions in the Aorta of ApoE-⁄- and Ovariectomized Mice with Correlation to Reduced MMP-2 Activity
   Keuri E. Rodrigues et al, 2022, International Journal of Molecular Sciences CrossRef
9. The role of the mineralocorticoid receptor in immune cells in cardiovascular disease
   Charlotte D. C. C. van der Heijden et al, 2022, British Journal of Pharmacology CrossRef
10. Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort study
    Imen Guizani et al, 2022, Molecular Biology Reports CrossRef
11. Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition
    Merry L. Lindsey et al, 2015, Cardiology CrossRef
12. The Relationship Between Simple Renal Cysts and Renal Function in Patients With Type 2 Diabetes
    Ling Wei et al, 2020, Frontiers in Physiology CrossRef
13. Collagen Molecular Damage is a Hallmark of Early Atherosclerosis Development
    Kelly A. Smith et al, 2023, Journal of Cardiovascular Translational Research CrossRef
14. Identification of Hub Genes and Pathways Associated With Idiopathic Pulmonary Fibrosis via Bioinformatics Analysis
    Hanxi Wan et al, 2021, Frontiers in Molecular Biosciences CrossRef
15. Network Pharmacology-Based to Analyze Screen Selaginella Doederleinii’s against Myocardial Ischemia
    思慧 李, 2021, Traditional Chinese Medicine CrossRef
16. Platelets at the Vessel Wall in Non-Thrombotic Disease
    Anu Aggarwal et al, 2023, Circulation Research CrossRef
17. Defective efferocytosis of vascular cells in heart disease
    Bandana Singh et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
18. ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1
    M. Amin Sharifi et al, 2023, Circulation Research CrossRef
19. Fisetin Attenuates Lipopolysaccharide-Induced Inflammatory Responses in Macrophage
    Yoshiko Hada et al, 2021, BioMed Research International CrossRef
20. Avenanthramide C Suppresses Matrix Metalloproteinase-9 Expression and Migration Through the MAPK/NF- κB Signaling Pathway in TNF-α-Activated HASMC Cells
    Junyoung Park et al, 2021, Frontiers in Pharmacology CrossRef
21. Relationship between the Activity of Matrix Metalloproteinase-2 and -9 in Myocardial Homogenate with Changes of the Cells Composition in the Coronary Arteries Wall in the Experiment
    null null et al, 2021, Ukraïnsʹkij žurnal medicini, bìologìï ta sportu CrossRef